Table 1.
SID | AGE | PD YRS | DBS MOS | UPDRS SPEECH | LEVO | L.AMP | R.AMP |
103 | 54 | 14 | 44 | 1 | 250 | 3.2 | 2.8 |
104 | 57 | 17 | 27 | 2 | 400 | 3.0 | 3.0 |
106 | 59 | 17 | 9 | 3 | 600 | 3.0 | 3.0 |
107 | 62 | 17 | 2 | 2 | 600 | 2.5 | 2.6 |
108 | 61 | 11 | 12 | 1 | 600 | 2.8 | 2.8 |
109 | 49 | 9 | 6 | 1 | 300 | 2.6 | 2.5 |
110 | 62 | 11 | 56 | 2 | 600 | 3.0 | 3.3 |
111 | 56 | 11 | 37 | 1 | 400 | 3.0 | 3.0 |
KEY: SID = subject identifier; AGE = in years; PD YRS = duration of PD; DBS MOS = duration of DBS therapy in months; UPDRS SPEECH = the speech rating in the UPDRS motor evaluation; LEVO = daily levodopa dose in mg; L.AMP = amplitude of stimulation on the left side; R.AMP = amplitude of stimulation on the right side. All stimulation was at 185 Hz with a pulse width of 60 micro seconds. The UPDRS SPEECH ratings are 0 (normal), 1 (slight loss of expression, diction, and/or voice, 2 (monotone, slurred, but understandable), 3 (marked impairment but difficult to understand), and 4 (unintelligible).